<DOC>
	<DOC>NCT01008033</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.</brief_summary>
	<brief_title>Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>Clinically diagnosed onychomycosis of the target nail Presence of mild to moderate onychomycosis, defined as 20 50% of the area of the target nail being clinically affected Has a positive KOH examination from the target nail Has a positive dermatophyte culture from the target nail Presence of any disease or condition that might cause nail abnormalities or may interfere with the evaluation of the study drug Use of any systemic antifungal therapy within 4 weeks prior to the Screening visit or nonresponsive to systemic antifungal therapy for onychomycosis Use of any prescription or overthecounter topical antifungal therapy for the toenails within 4 weeks prior to the Screening visit Woman who is pregnant, nursing an infant, or planning a pregnancy during the study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>